Showing results (271-280 of 312) with videos related to

Sort By:
Pageof 32
Clinical and Experimental Immunology|October 2, 2008
Single cell analysis of B lymphocytes from Wegener's granulomatosis: B cell receptors display affinity maturation within the granulomatous lesionsJ Voswinkel, G Assmann, G Held, et al.
Annals of the Rheumatic Diseases|December 4, 2014
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)A J Mohammad, A Hot, F Arndt, et al.
Journal of Immunological Methods|September 20, 1991
A human renal cancer line as a new antigen source for the detection of antibodies to cytoplasmic and nuclear antigens in sera of patients with Wegener's granulomatosisW J Mayet, E Hermann, E Csernok, et al.
Clinical and Experimental Immunology|September 1, 2001
Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitisE Peen, C Malone, C Myers, et al.
Arthritis and Rheumatism|May 19, 2000
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patientsE Reinhold-Keller, N Beuge, U Latza, et al.
Klinische Monatsblatter Fur Augenheilkunde|November 1, 1992
[Orbital involvement in Wegener's granulomatosis]G Duncker, W L Gross, B Nölle, et al.
Immunitat Und Infektion|February 1, 1992
[A new type of ANCA in sera of patients with ulcerative colitis: effects of therapy and disease severity on serum titer]J A Rump, M Roth, J Schölmerich, et al.
Rheumatology (Oxford, England)|May 16, 2002
No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis registerE Reinhold-Keller, K Herlyn, R Wagner-Bastmeyer, et al.
Annals of the Rheumatic Diseases|November 5, 2005
Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestationsP M Aries, B Hellmich, J Voswinkel, et al.
Arthritis and Rheumatism|June 1, 1994
Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosisE Reinhold-Keller, J Kekow, A Schnabel, et al.
Pageof 32